Trial record 1 of 1 for:
Ga101-DHAP | Lymphoma | Italy
Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients (GIOTTO)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02374424 |
|
Recruitment Status :
Completed
First Posted : February 27, 2015
Last Update Posted : October 30, 2020
|
Sponsor:
Fondazione Italiana Linfomi ONLUS
Information provided by (Responsible Party):
Fondazione Italiana Linfomi ONLUS
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | February 2018 |
| Actual Study Completion Date : | June 23, 2020 |